Form 4 for STE Steris
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001628280-25-027284 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-22 | 2025-05-20 | STE | Majors Cary L | SVP, Pres, Healthcare | S - Sale+OE | $250.08 | -12.8K | 16.0K | -45% | -$3.21M |
| D | 2025-05-22 | 2025-05-20 | STE | Majors Cary L | SVP, Pres, Healthcare | M - OptEx | $147.05 | +12.8K | 24.2K | +113% | +$1.89M |
| D | 2025-05-22 | 2025-05-20 | STE | Majors Cary L | SVP, Pres, Healthcare | M - OptEx | $0.00 | -12.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-05-20 | S | D | 4,581 | $250.71 | 11,372 | D | — | — | (F3) Price reflects a weighted average sale price for multiple transactions ranging from $250.50 to $251.04 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F1) As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. |
| 2 | Common | Ordinary Shares | 2025-05-20 | S | D | 8,247 | $249.73 | 15,953 | D | — | — | (F2) Price reflects a weighted average sale price for multiple transactions ranging from $249.46 to $250.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F1) As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. |
| 3 | Common | Ordinary Shares | 2025-05-20 | M | A | 12,828 | $147.05 | 24,200 | D | — | — | (F1) As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-05-20 | M | D | 12,828 | $0.00 | 0 | D | $147.05 · — to 2029-05-31 | 12,828 Ordinary Shares | (F5) This option is fully vested. |